Clinical trial
Randomized and Controlled Clinical Study of High-dose Dual Therapy with Different Administration Frequencies in the Treatment of Helicobacter Pylori
NCT05901051 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized and Controlled Clinical Study of High-dose Dual Therapy with Different Administration Frequencies in the Treatment of Helicobacter Pylori
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 30, 2021
- Completion date
- September 30, 2023
- Enrollment
- 327 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter pylori infection